Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey.

MLA

Yamazhan, Tansu, et al. “Real-Life Experience of Ledipasvir and Sofosbuvir Single-Tablet Regimen among Chronic Hepatitis C Patients in Turkey.” The Turkish Journal of Gastroenterology : The Official Journal of Turkish Society of Gastroenterology, vol. 31, no. 3, Mar. 2020, pp. 239–45. EBSCOhost, https://doi.org/10.5152/tjg.2020.19076.

APA

Yamazhan, T., Turan, İ., Ersöz, G., Günşar, F., Pullukçu, H., Danış, N., Ünal, N. G., Vardar, R., Oruç, N., Tekin, F., Taşbakan, M., Sipahi, O. R., & Akarca, U. S. (2020). Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey. The Turkish Journal of Gastroenterology : The Official Journal of Turkish Society of Gastroenterology, 31(3), 239–245. https://doi.org/10.5152/tjg.2020.19076

Chicago

Yamazhan, Tansu, İlker Turan, Galip Ersöz, Fulya Günşar, Hüsnü Pullukçu, Nilay Danış, Nalan G Ünal, et al. 2020. “Real-Life Experience of Ledipasvir and Sofosbuvir Single-Tablet Regimen among Chronic Hepatitis C Patients in Turkey.” The Turkish Journal of Gastroenterology : The Official Journal of Turkish Society of Gastroenterology 31 (3): 239–45. doi:10.5152/tjg.2020.19076.